| 序号 |
标题 |
次数 |
作者 |
发布时间 |
| 83026 |
Au-S-Polymer-Doxorubicin 金-硫-聚合物-阿霉素 |
142 |
h |
2024-12-20 |
| 83027 |
(S-(EG)3-CH2-CONH-Fluorescein)2 硫-三聚乙二醇-烷烃-CONH-荧光素 |
160 |
h |
2024-12-19 |
| 83028 |
Ag_55_C15COOH 银团簇55-C15-羧基 |
124 |
h |
2024-12-19 |
| 83029 |
Ag-S-(CH2)11-NH3+Cl- 银-硫-十一烷烃-NH3+Cl- |
194 |
h |
2024-12-19 |
| 83030 |
Au-S-Zwitterion 金-硫-两性离子 |
164 |
h |
2024-12-19 |
| 83031 |
Au_12_C11NMe3 金12碳11纳米团簇 |
167 |
h |
2024-12-19 |
| 83032 |
Au_55_C10COOH 金团簇55-C10-羧酸 |
122 |
h |
2024-12-19 |
| 83033 |
Au-S-(CH2)10-C(O)-CH3 金-硫-直链烷烃10-碳(氧)-甲烷3 |
173 |
h |
2024-12-19 |
| 83034 |
MC-Val-Cit-PAB-tubulysin5a ,CAS号:2055896-86-9 |
115 |
WYQ |
2024-12-19 |
| 83035 |
Au_55_C11NH3Cl 金55-C11-NH3Cl |
147 |
h |
2024-12-19 |
| 83036 |
(S-(CH2)11-(beta-Lactose(SO4Na)7)2 硫-十一烷烃-β-乳糖 |
161 |
h |
2024-12-19 |
| 83037 |
HS-(CH2)11-O-Disperse Red 1 十一烷烃硫醇化荧光配体 |
233 |
h |
2024-12-19 |
| 83038 |
HS-(CH2)16-(EG)2 -N(+)(CH3)2-CH2-COO(-) 二聚乙二醇化十六硫醇 |
164 |
h |
2024-12-19 |
| 83039 |
cas:103750-03-4,5-Maleimido-pentanoic NHS ester,5-马来酰亚胺戊酸NHS |
163 |
kx |
2024-12-19 |
| 83040 |
4-Nitrophenyl 2-(pyridin-2-yldisulfanyl)propyl carbonate,抗体药物偶联物(ADC) |
158 |
kx |
2024-12-19 |
| 83041 |
cas:158913-22-5,SPDP-C6-NHS ester,琥珀酰亚胺基6-[3-(2-吡啶基二硫代)丙酰胺基]己酸酯 |
159 |
kx |
2024-12-19 |
| 83042 |
perfluorophenyl 4-methyl-4-(pyridin-2-yldisulfanyl)pentanoate,抗体药物偶联物(ADC) |
165 |
kx |
2024-12-19 |
| 83043 |
cas:663598-61-6,2,5-dioxopyrrolidin-1-yl 4-((5-nitropyridin-2-yl)disulfanyl)pentanoate, ADC试剂 |
134 |
kx |
2024-12-19 |
| 83044 |
perfluorophenyl 4-(pyridin-2-yldisulfanyl)butanoate, ADC试剂 |
122 |
kx |
2024-12-19 |
| 83045 |
cas:160580-70-1,perfluorophenyl 3-(pyridin-2-yldisulfanyl)propanoate,抗体药物偶联物(ADC) |
179 |
kx |
2024-12-19 |
| 83046 |
cas:252554-78-2, Fmoc-Ala-Ser(Psi(Me Me)pro)-OH,(4S)-3-[(2S)-2-[[(9H-芴-9-甲氧基)羰基]氨基]-1-氧代丙基]-2,2-二甲基-4-恶唑烷羧酸 |
201 |
kx |
2024-12-19 |
| 83047 |
MC-Val-Cit-PAB-Indibulin, cas:2055896-95-0 |
142 |
WYQ |
2024-12-19 |
| 83048 |
cas:1884578-27-1 ,Alloc-Val-Ala-PAB-PNP,N-[(2-丙烯-1-基氧基)羰基]-L-缬氨酸-N-[4-[[(4-硝基苯氧基)羰基]氧基]甲基]苯基]-L-丙氨酸酰胺 |
171 |
kx |
2024-12-19 |
| 83049 |
mDPR-Val-Cit-PAB-MMAE(CAS:1491152-26-1) |
142 |
WYQ |
2024-12-19 |
| 83050 |
2,5-dioxopyrrolidin-1-yl 1-(bicyclo[6.1.0]non-4-yn-9-yl)-3-oxo-2,7,10,13-tetraoxa-4-azahexadecan-16-oate |
143 |
wyh |
2024-12-19 |
| 83051 |
MC-Val-Cit-PAB-vinblastine(CAS:2055896-92-7) |
141 |
WYQ |
2024-12-19 |
| 83052 |
2,5-dioxopyrrolidin-1-yl 1-(bicyclo[6.1.0]non-4-yn-9-yl)-3-oxo-2,7,10,13-tetraoxa-4-azahexadecan-16-oate |
136 |
wyh |
2024-12-19 |
| 83053 |
MC-Val-Cit-PAB-tubulysin5a(CAS:2055896-86-9) |
126 |
WYQ |
2024-12-19 |
| 83054 |
N-芴甲氧羰基-四聚乙二醇-VAL-ALA-PAB, Fmoc-PEG4-Val-Ala-PAB |
165 |
kx |
2024-12-19 |
| 83055 |
MC-Val-Cit-PAB-clindamycin(CAS号:1639793-13-7) |
125 |
WYQ |
2024-12-19 |
| 83056 |
MC-Val-Cit-PAB-carfilzomib,CAS号:2055896-83-6 |
151 |
WYQ |
2024-12-19 |
| 83057 |
叔丁酯-四聚乙二醇-VAL-ALA-PAB,Boc-PEG4-Val-Ala-PAB |
127 |
kx |
2024-12-19 |
| 83058 |
MC-Val-Cit-PAB-Auristatin E,CAS号:2055896-77-8 |
154 |
WYQ |
2024-12-19 |
| 83059 |
MC-Sq-Cit-PAB-Gefitinib(CAS:1941168-63-3) |
221 |
WYQ |
2024-12-19 |
| 83060 |
HS-(CH2)m-(EG)n -N(+)(CH3)2-CH2-COO(-) 聚乙二醇化直链烷烃硫醇 |
146 |
h |
2024-12-19 |
| 83061 |
Mal-PEG4-Val-Ala-PAB,马来酰亚胺-四聚乙二醇-VAL-ALA-PAB |
190 |
kx |
2024-12-19 |
| 83062 |
MC-GGFG-DX8951(CAS:1600418-29-8) |
412 |
WYQ |
2024-12-19 |
| 83063 |
(HO)2-PO-S-(CH2)6-EG2-OH 硫-(2-羟基六烷-1-基)硫代磷酸酯 |
181 |
h |
2024-12-19 |
| 83064 |
Au_55_C11EG4Carboxybetaine 金团簇55-羧基甜菜碱 |
224 |
h |
2024-12-19 |
| 83065 |
(HO)2-PO-S-(CH2)m-COONHS 硫-(2,5-二氧代 - 吡咯烷-1-基氧基羰基)-1-基硫代磷酸 |
163 |
h |
2024-12-19 |
| 83066 |
2529982-76-9,Azido-PEG4-Val-Ala-PAB,叠氮-四聚乙二醇-VAL-ALA-PAB |
168 |
kx |
2024-12-19 |
| 83067 |
Au_12_C11EG6 金团簇12-直链烷烃六聚乙二醇 |
207 |
h |
2024-12-19 |
| 83068 |
cas:863971-17-9 ,MC-Val-Cit-PAB-MMAF,MC-VAL-CIT-PAB-MMAF游离态 |
137 |
kx |
2024-12-19 |
| 83069 |
CF3-(CF2)5-C2-O-C11-Si(OMe)3 巯基-直链烷烃连接氟化硫醇和硅烷 |
174 |
h |
2024-12-19 |
| 83070 |
cas:2353409-69-3 , Mal-PEG8-Val-Cit-PAB-MMAE,马来酰亚胺-八聚乙二醇-VAL-CIT-PAB-MMAE |
161 |
kx |
2024-12-19 |